| Long name | ADORA1 Primary Polyclonal Antibody |
| Also known as | ADORA1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | ADORA1 |
| Specificity | This is a highly specific antibody against ADORA1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 147-176/326 |
| Subcellular location | Extracellular |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ADORA1 |
| Gene ID number | 134 |
| Swiss Prot | P30542 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase, Receptor for adenosine |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | ADORA1, Adenosine receptor A1, RDC7 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | ADORA1 |
| Short name | ADORA1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | adenosine A1 receptor (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | ADORA1 and IDBG-105921 and ENSG00000163485 and 134, ADORA1 and IDBG-628574 and ENSBTAG00000011461 and 282133, Adora1 and IDBG-193467 and ENSMUSG00000042429 and 11539, GABAergic and biological process this GO :0032244 and positive regulation of nucleoside transport and biological process this GO :0032279 and asymmetric synapse and cellular component this GO :0032795 and heterotrimeric G-protein binding and molecular function this GO :0032900 and negative regulation of neurotrophin production and biological process this GO :0035307 and positive regulation of protein dephosphorylation and biological process this GO :0035814 and negative regulation of renal sodium excretion and biological process this GO :0042321 and negative regulation of circadian sleep/wake cycle, Plasma membranes, RDC7, glutamatergic and biological process this GO :0055117 and regulation of cardiac muscle contraction and biological process this GO :0055118 and negative regulation of cardiac muscle contraction and biological process this GO :0060079 and regulation of excitatory postsynaptic membrane potential and biological process this GO :0060087 and relaxation of vascular smooth muscle and biological process this GO :0070256 and negative regulation of mucus secretion and biological process this GO :0097190 and apoptotic signaling pathway and biological process, non-REM sleep and biological process this GO :0042734 and presynaptic membrane and cellular component this GO :0043025 and neuronal cell body and cellular component this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043195 and terminal bouton and cellular component this GO :0043268 and positive regulation of potassium ion transport and biological process this GO :0044297 and cell body and cellular component this GO :0045211 and postsynaptic membrane and cellular component this GO :0045741 and positive regulation of epidermal growth factor-activated receptor activity and biological process this GO :0045776 and negative regulation of blood pressure and biological process this GO :0045777 and positive regulation of blood pressure and biological process this GO :0045822 and negative regulation of heart contraction and biological process this GO :0045908 and negative regulation of vasodilation and biological process this GO :0046888 and negative regulation of hormone secretion and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048167 and regulation of synaptic plasticity and biological process this GO :0048786 and presynaptic active zone and cellular component this GO :0050728 and negative regulation of inflammatory response and biological process this GO :0050890 and cognition and biological process this GO :0050965 and detection of temperature stimulus involved in sensory perception of pain and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051930 and regulation of sensory perception of pain and biological process this GO :0051967 and negative regulation of synaptic transmission, protein heterodimerization activity, sleep and biological process this GO :0042323 and negative regulation of circadian sleep/wake cycle, this GO :0000186 and activation of MAPKK activity and biological process this GO :0001609 and G-protein coupled adenosine receptor activity and molecular function this GO :0001659 and temperature homeostasis and biological process this GO :0001664 and G-protein coupled receptor binding and molecular function this GO :0001666 and response to hypoxia and biological process this GO :0001883 and purine nucleoside binding and molecular function this GO :0001973 and adenosine receptor signaling pathway and biological process this GO :0002087 and regulation of respiratory gaseous exchange by neurological system process and biological process this GO :0002674 and negative regulation of acute inflammatory response and biological process this GO :0002686 and negative regulation of leukocyte migration and biological process this GO :0002793 and positive regulation of peptide secretion and biological process this GO :0003093 and regulation of glomerular filtration and biological process this GO :0004629 and phospholipase C activity and molecular function this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006612 and protein targeting to membrane and biological process this GO :0006909 and pha this GO cytosis and biological process this GO :0006954 and inflammatory response and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007193 and adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007399 and nervous system development and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0012505 and endomembrane system and cellular component this GO :0014050 and negative regulation of glutamate secretion and biological process this GO :0014069 and postsynaptic density and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016042 and lipid catabolic process and biological process this GO :0016323 and basolateral plasma membrane and cellular component this GO :0030425 and dendrite and cellular component this GO :0030673 and axolemma and cellular component this GO :0031683 and G-protein beta/gamma-subunit complex binding and molecular function this GO :0032229 and negative regulation of synaptic transmission, this GO :0001609: G-protein coupled adenosine receptor activity, this GO :0001609: G-protein coupled adenosine receptor activity and also this GO :0001664: G-protein coupled receptor binding and also this GO :0001883: purine nucleoside binding and also this GO :0004629: phospholipase C activity and also this GO :0004930: G-protein coupled receptor activity and also this GO :0005515: protein binding and also this GO :0031683: G-protein beta/gamma-subunit complex binding and also this GO :0032795: heterotrimeric G-protein binding and also this GO :0046982: protein heterodimerization activity, this GO :0001664: G-protein coupled receptor binding, this GO :0001883: purine nucleoside binding, this GO :0004629: phospholipase C activity, this GO :0004930: G-protein coupled receptor activity, this GO :0005515: protein binding, this GO :0031683: G-protein beta/gamma-subunit complex binding, this GO :0032795: heterotrimeric G-protein binding, this GO :0046982: protein heterodimerization activity, 787449, adenosine A1 receptor |
| Identity | 262 |
| Gene | ADORA1 |
| Long gene name | adenosine A1 receptor |
| Synonyms | RDC7 |
| Locus | 1q32, 1 |
| Discovery year | 1991-03-11 |
| GenBank acession | BC026340 |
| Entrez gene record | 134 |
| Pubmed identfication | 1662665 2541503 |
| RefSeq identity | NM_000674 |
| Classification | Adenosine receptors |
| Havana BLAST/BLAT | OTTHUMG00000042125 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue